PV Bulletin

Injunction No. 2026-DM-031-INJ Regarding Ortho Partner Establishment in Montreuil

ANSM issued an injunction for Ortho Partner to implement specific compliance measures.

Primary source: ANSM (France) - News feed

Translated From French

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

Urgency: HighConfidence: high

What changed

Ortho Partner is required to establish compliant storage conditions for medical devices and implement a system for managing non-conformities, complaints, vigilance, recalls, and withdrawals within 3 months.

Why it matters

This injunction could significantly impact operational compliance and oversight at the specified facility, ensuring that medical products are stored correctly and that non-conformities are managed effectively.

Action needed

Establish compliant storage conditions for medical devices and set up a non-conformity management system within 3 months.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Inspection Readiness
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 7, 2026

Full briefing

Practical implication

Establish compliant storage conditions for medical devices and set up a non-conformity management system within 3 months.

The ANSM has ordered the establishment of Ortho Partner located in Montreuil to comply with specific requirements concerning the storage conditions of medical devices and to create a system for managing non-conformities. This action must be completed within a period of 3 months.

What changed: Ortho Partner is required to establish compliant storage conditions for medical devices and implement a system for managing non-conformities, complaints, vigilance, recalls, and withdrawals within 3 months.

Why it matters: This injunction could significantly impact operational compliance and oversight at the specified facility, ensuring that medical products are stored correctly and that non-conformities are managed effectively.

Practical implication: Establish compliant storage conditions for medical devices and set up a non-conformity management system within 3 months.

View original source

  • Source: ANSM (France) - News feed
  • Published at source: 2026-09-07T00:00:00.000Z
  • Discovered by monitor: 2026-09-07T21:36:51.572Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward